Gynäkologisch-geburtshilfliche Rundschau
Originalarbeit
Erfolgskontrolle und Lebensqualität nach Myomembolisation: LangzeitergebnisseHirzel F.a · Hess T.b · Zollikofer C.aaInstitut für Radiologie und bFrauenklinik, Kantonsspital Winterthur, Winterthur, Schweiz
|
|
Log in to MyKarger to check if you already have access to this content.
KAB
Buy a Karger Article Bundle (KAB) and profit from a discount!
If you would like to redeem your KAB credit, please log in.
Save over 20% compared to the individual article price.
Subscribe
For eJournal Archive and eJournal Backfiles information please contact Karger service
Article / Publication Details
Received: January 20, 2007
Accepted: August 13, 2007
Published online: April 16, 2008
Issue release date: April 2008
Number of Print Pages: 10
Number of Figures: 6
Number of Tables: 2
ISSN: 1018-8843 (Print)
eISSN: 1423-0011 (Online)
For additional information: https://www.karger.com/GGR
First-Page Preview
Related Articles:
Literatur
- Buttram VC Jr, Reiter RC: Uterine leiomyomata: etiology, symptomatology, and management. Fertil Steril 1981;36:433–445.
- Cramer SF, Patel A: The frequency of uterine leiomyomas. Am J Clin Pathol 1990;94:435–438.
- Rice JP, Kay HH, Mahony BS: The clinical significance of uterine leiomyomas in pregnancy. Am J Obstet Gynecol 1989;160:1212–1216.
- Farquhar CM, Steiner CA: Hysterectomy rates in the United States 1990–1997. Obstet Gynecol 2002;99:229–234.
- Carlson KJ, Miller BA, Fowler FJ Jr: The Maine Women’s Health Study. I. Outcomes of hysterectomy. Obstet Gynecol 1994;83:556–565.
- Kjerulff KH, Langenberg PW, Rhodes JC, Harvey LA, Guzinski GM, Strolley PD: Effectiveness of hysterectomy. Obstet Gynecol 2000;95:319–326.
-
Brechin S, Farquharson DM, Hawthorn R, Davis J, Fisher P, Philips W, Lumsden MA: A Scottish audit of laparoscopically assisted vaginal hysterectomy. Gynaecol Endosc 2000;9:233–238.
External Resources
- Stewart EA: Uterine fibroids. Lancet 2001;357:293–298.
-
Haussegger KA, Schreyer H, Bodhal H: Beckenarterienembolisation bei gynäkologischen Blutungen. Fortschr Röntgenstr 2002;174:809–818.
- Ravina JH, Herbreteau D, Ciraru-Vigneron N, Bouret JM, Houdart E, Aymard A, Merland JJ: Arterial embolization to treat uterine myomata. Lancet 1995;346:671–672.
- Pron G, Bennett J, Common A, Wall J, Asch M, Sniderman K: The Ontario Uterine Fibroid Embolization Trial. 2. Uterine fibroid reduction and symptom relief after uterine artery embolization for fibroids. Fertil Steril 2003;79:120–127.
-
Walker WJ, Pelage JP: Uterine artery embolization for symptomatic fibroids: clinical results in 400 women with imaging follow-up. Br J Obstet Gynaecol 2002;109:1262–1272.
External Resources
-
Spies JB, Myers ER, Worthington-Kirsch R, Mulgund J, Goodwin S, Mauro M: The FIBROID registry: symptom and quality-of-life status 1 year after therapy. Am J Obstet Gynecol 2005;106:1309–1318.
- Smith WJ, Upton E, Shuster EJ, Klein AJ, Schwartz ML: Patient satisfaction and disease specific quality of life after uterine artery embolization. Am J Obstet Gynecol 2004;190:1697–1706.
- Scheurig C, Gauruder-Burmester A, Kluner C, Kurzeja R, Lembcke A, Zimmermann E, Hamm B, Kroencke T: Uterine artery embolization for symptomatic fibroids: short-term versus mid-term changes in disease-specific symptoms, quality of life and magnetic resonance imaging results. Hum Reprod 2006;21:3270–3277.
- Spies JB, Coyne K, Guaou Guaou N, Boyle D, Skyrnarz-Murphy K, Gonzalves SM: The UFS-QOL, a new disease-specific symptom and health-related quality of life questionnaire for leiomyomata. Obstet Gynecol 2002;99:290–300.
- Naughton MJ, McBee WL: Health-related quality of life after hysterectomy. Clin Obstet Gynecol 1997;40:947–957.
- Nevadunsky NS, Bachmann GA, Nosher J, Yu T: Women’s decision-making determinants in chosing uterine artery embolisation for symptomatic fibroids. J Reprod Med 2001;46:870–874.
- Rock JA: Quality-of-life assessment in gynecologic surgery. J Reprod Med 2001;46:515–519.
- Ranstad T, Eikeland O, Helland H, Qvarnstrom U: The quality of life in women suffering from gynecological disorders is improved by means of hysterectomy: absolute and relative differences between pre- and postoperative measures. Acta Obstet Gynecol Scand 2001;80:46–51.
- Broder MS, Goodwin S, Chen G, Tang LJ, Constantino MM, Nguyen MH, Yegul TN, Erberich H: Comparison of long-term outcomes of myomectomy and uterine artery embolisation. Obstet Gynecol 2002;100:864–868.
- Kjerulff KH, Rhodes JC, Lagenberg PW, Harvey LA: Patient satisfaction with results of hysterectomy. Am J Obstet Gynecol 2000;183:1440–1447.
- Brunerau L, Herbreteau D, Gallas S, Cottier J, Lebrun J, Tranquart F, Fauchier F, Body G, Rouleau P: Uterine artery embolisation in the primary treatment of uterine leiomyomas: technical features and prospective follow-up with clinical and sonographic examinations in 58 patients. AJR Am J Roentgenol 2000;175:1267–1272.
- Spies JB, Ascher SA, Roth AR, Kim J, Levy EB, Gomez-Jorge J: Uterine artery embolization for leiomyomata. Obstet Gynecol 2001;98:29–34.
- Pelage J, Le Dref O, Soyer P, Kardache M, Dahan H, Abitol M, Merland JJ, Ravina JH, Rymer R: Fibroid-related menorrhagia: treatment with superselective embolization of the uterine arteries and midterm follow-up. Radiology 2000;215:428–431.
- Goodwin SC, McLucas B, Lee M, Chen G, Perrella R, Vedantham S, Muir S, Lai A, Sayre JW, DeLeon M: Uterine artery embolization for the treatment of uterine leiomyomata midterm results. J Vasc Interv Radiol 1999;10:1159–1165.
- Spies JB, Roth AR, Jha RC, Gomez-Jorge J, Levy EB, Chang TC, Ascher SA: Leiomyomata treated with uterine artery embolization: factors associated with successful symptom and imaging outcome. Radiology 2002;222:45–52.
- Tulandi T, Sammour A, Valentini D, Child TJ, Seti L, Tau SL: Ovarian reserve after artery embolization for leimyomata. Fertil Steril 2002;78:197–198.
- Tropeano G, Di Stasi C, Litwicka K, Romano D, Draisci G, Mancuso S: Uterine artery embolization for fibroids does not have adverse effects on ovarian reserve in regularly cycling women younger than 40 years. Fertil Steril 2004;81:1055–1061.
- Ahmad A, Qadan L, Hassan N, Najarian K: Uterine artery embolization treatment of uterine fibroids: effect on ovarian function in younger women. J Vasc Interv Radiol 2002;13:1017–1020.
- Healey S, Buzaglo K, Seti L, Valenti D, Tulandi T: Ovarian function after uterine artery embolization and hysterectomy. J Am Assoc Gynecol Laparosc 2004;11:348–352.
-
Payne JF, Robboy SJ, Haney AF: Embolic microspheres within ovarian arterial vasculature after uterine artery embolization. Obstet Gynecol 2002;100:883–886.
External Resources
- Stone SC, Dickey RP, Mickal A: The acute effect of hysterectomy on ovarian function. Am J Obstet Gynecol 1975;121:193–197.
- Janson PO, Jansson I: The acute effect of hysterectomy on ovarian blood flow. Am J Obstet Gynecol 1977;127:349–352.
- Siddle N, Sarrel P, Whitehead M: The effect of hysterectomy on the age at ovarian failure: identification of a subgroup of women with premature loss of ovarian function and literature review. Fertil Steril 1987;47:94–100.
- Farquar CM, Sadler L, Harvey SA, Stewart AW: The association of hysterectomy and menopause: a prospective cohort study. BJOG 2005;112:956–962.
- Marret H, Alonso AM, Cottier JP, Tranquart F, Herbreteau D, Body G: Leiomyoma recurrence after uterine artery embolization. J Vasc Interv Radiol 2003;14:1395–1399.
- Spies JB, Spector A, Roth AR, Baker CM, Mauro L, Murphy-Skrynarz K: Complications after uterine artery embolization for leiomyomas. Obstet Gynecol 2002;100:873–880.
- Edwards RD, Moss JG, Lumsden MA, Wu O, Murray LS, Twaddle S, Murray GD: Uterine-artery embolization versus surgery for symptomatic uterine fibroids. N Engl J Med 2007;356:360–370.
- Pron G, Mocarski E, Bennett J, et al: Pregnancy after uterine artery embolisation for leiomyomata: the Ontario Multicenter Trial. Obstet Gynecol 2005;105:67–76.
- Carpenter TT, Walker WJ: Pregnancy following uterine artery embolisation for symptomatic fibroids: a series of 26 completed pregnancies. BJOG 2005;112:321–325.
Article / Publication Details
Received: January 20, 2007
Accepted: August 13, 2007
Published online: April 16, 2008
Issue release date: April 2008
Number of Print Pages: 10
Number of Figures: 6
Number of Tables: 2
ISSN: 1018-8843 (Print)
eISSN: 1423-0011 (Online)
For additional information: https://www.karger.com/GGR
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
Get Permission